BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29303660)

  • 21. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
    Holt SE; Brown EJ; Zipursky A
    J Pediatr Hematol Oncol; 2002 Jan; 24(1):14-7. PubMed ID: 11902731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
    de Rooij JD; Hollink IH; Arentsen-Peters ST; van Galen JF; Berna Beverloo H; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Zimmermann M; Alonzo TA; Pieters R; Meshinchi S; van den Heuvel-Eibrink MM; Zwaan CM
    Leukemia; 2013 Dec; 27(12):2280-8. PubMed ID: 23531517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
    Savaşan S; Buck S; Raimondi SC; Becton DL; Weinstein H; Chang M; Ravindranath Y
    Leuk Lymphoma; 2006 Oct; 47(10):2076-83. PubMed ID: 17071479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute megakaryoblastic leukemia in Down syndrome.
    Hitzler JK
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.
    Hama A; Yagasaki H; Takahashi Y; Nishio N; Muramatsu H; Yoshida N; Tanaka M; Hidaka H; Watanabe N; Yoshimi A; Matsumoto K; Kudo K; Kato K; Horibe K; Kojima S
    Br J Haematol; 2008 Mar; 140(5):552-61. PubMed ID: 18275433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.
    Masetti R; Guidi V; Ronchini L; Bertuccio NS; Locatelli F; Pession A
    Crit Rev Oncol Hematol; 2019 Jun; 138():132-138. PubMed ID: 31092368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute leukemia in patients with Down syndrome].
    Fernández-Plaza S; Sevilla J; Contra T; Martín N; Madero L
    An Pediatr (Barc); 2004 Dec; 61(6):515-9. PubMed ID: 15574252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
    de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F
    Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
    de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA
    Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several?
    Lu G; Altman AJ; Benn PA
    Cancer Genet Cytogenet; 1993 Jun; 67(2):81-9. PubMed ID: 8330276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
    Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
    Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
    Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
    Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
    Cetin N; Lorsbach RB
    Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal manifestations of pediatric acute megakaryoblastic leukemia.
    Athale UH; Kaste SC; Razzouk BI; Rubnitz JE; Ribeiro RC
    J Pediatr Hematol Oncol; 2002 Oct; 24(7):561-5. PubMed ID: 12368696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute myeloid leukemia in children with Down syndrome].
    Creutzig U; Ritter J; Ludwig WD; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
    Klin Padiatr; 1995; 207(4):136-44. PubMed ID: 7564143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation.
    Yakoub-Agha I; de La Salmonière P; Ribaud P; Sutton L; Wattel E; Kuentz M; Jouet JP; Marit G; Milpied N; Deconinck E; Gratecos N; Leporrier M; Chabbert I; Caillot D; Damaj G; Dauriac C; Dreyfus F; François S; Molina L; Tanguy ML; Chevret S; Gluckman E
    J Clin Oncol; 2000 Mar; 18(5):963-71. PubMed ID: 10694545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Megakaryoblastic Leukemia with Trisomy 21 and Tetrasomy 21 Clones in a Phenotypically Normal Child with Mosaic Trisomy 21.
    Won E; Gruber TA; Tucker S; Schiff DE
    Case Rep Pediatr; 2020; 2020():7813048. PubMed ID: 32257492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.
    Massey GV; Zipursky A; Chang MN; Doyle JJ; Nasim S; Taub JW; Ravindranath Y; Dahl G; Weinstein HJ;
    Blood; 2006 Jun; 107(12):4606-13. PubMed ID: 16469874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome.
    Lightfoot J; Hitzler JK; Zipursky A; Albert M; Macgregor PF
    Leukemia; 2004 Oct; 18(10):1617-23. PubMed ID: 15343346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.